To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Middle Eastern/Arab Americans represent a large, heterogeneous and quickly growing population in the U.S. Health statistics for this group are difficult to find because Arab is not a recognized category for race/ethnicity by the U.S. Census. Program members have developed and validated a naming algorithm to enhance research in a population that makes up a large portion of our catchment area. This algorithm has a positive predictive value of 91% and a negative predictive value of 100%. Using this approach in SEER data in metropolitan Detroit, California and New Jersey, we find that Arab American men and women had similar incidence rates across the three regions and rates were comparable to non-Hispanic, non-Arab whites. Among women, however, rates of thyroid were elevated; among men, rates of bladder cancer we elevated. Arab American men also had lower overall rates of cancer and rates of prostate and lung cancer than African Americans, but higher incidence than Hispanics. To evaluate the excess rate of thyroid cancer among Arab American women, program members compared risk factors to non-Hispanic white women with this disease. Arab American women had significantly higher exposures to dental x-rays and medical radiation than non-Hispanic white women.
For 30 years, Michael Cher, M.D. , urologic oncologist, chief of Urology and member of the Genitourinary Oncology Multidisciplinary Team (MDT), ha...
“If you care about your life and your family members, get the screenings because they are important." Lung cancer is still the leading cause of ca...
The Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations nationwide, recognizes November as Pancreatic Cancer...